Literature DB >> 16465523

[Application of tissue microarrays for the diagnosis, prognosis and therapeutic decision making in renal cell carcinoma].

A S Merseburger1, J Hennenlotter, D Schilling, K D Sievert, R Küfer, M A Kuczyk.   

Abstract

The tissue microarray technique (TMA) represents a powerful diagnostic "high-throughput" tool to analyse DNA/RNA or protein alterations in large patient cohorts in a time and cost effective way. This review focuses on the clinical application of TMA in renal cell carcinoma in modern "translational" medicine--"from bench to bedside". In particular, the advantages of TMA for diagnosis, prognosis and decisions for therapy will be considered in relation to renal cell cancer.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16465523     DOI： 10.1007/s00120-006-1005-y

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  15 in total

1.  Limitations of tissue microarrays in the evaluation of focal alterations of bcl-2 and p53 in whole mount derived prostate tissues.

Authors:  Axel S Merseburger; Markus A Kuczyk; Jurgen Serth; Carsten Bokemeyer; Denise Y Young; Leon Sun; Roger R Connelly; David G McLeod; Fathollah K Mostofi; Shiv K Srivastava; A Stenzl; Judd W Moul; Isabell A Sesterhenn
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

Review 2.  [Tissue microarrays. High-throughput procedures to verify potential biomarkers].

Authors:  R Kuefer; M D Hofer; J E Gschwend; M A Rubin
Journal:  Urologe A       Date:  2004-06       Impact factor: 0.639

3.  Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma.

Authors:  E R Sargent; L G Gomella; A Belldegrun; W M Linehan; A Kasid
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

Review 4.  Cathepsin D in cancer metastasis: a protease and a ligand.

Authors:  H Rochefort; E Liaudet-Coopman
Journal:  APMIS       Date:  1999-01       Impact factor: 3.205

5.  Expression of the free beta-subunit of human chorionic gonadotropin in renal cell carcinoma: prognostic study on tissue and serum.

Authors:  Kristina Hotakainen; Börge Ljungberg; Caj Haglund; Stig Nordling; Annukka Paju; Ulf-Hakan Stenman
Journal:  Int J Cancer       Date:  2003-05-01       Impact factor: 7.396

6.  P63 immunoreactivity distinguishes upper urinary tract transitional-cell carcinoma and renal-cell carcinoma even in poorly differentiated tumors.

Authors:  Cord Langner; Manfred Ratschek; Oleksiy Tsybrovskyy; Luigi Schips; Richard Zigeuner
Journal:  J Histochem Cytochem       Date:  2003-08       Impact factor: 2.479

7.  Cathepsin D and epidermal growth factor receptor immunohistochemistry does not predict recurrence of prostate cancer in patients undergoing radical prostatectomy.

Authors:  J W Moul; S J Maygarden; J L Ware; J L Mohler; P D Maher; N S Schenkman; C K Ho
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

8.  Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?

Authors:  Janet E Dancey
Journal:  J Clin Oncol       Date:  2004-06-21       Impact factor: 44.544

9.  Tissue microarrays for high-throughput molecular profiling of tumor specimens.

Authors:  J Kononen; L Bubendorf; A Kallioniemi; M Bärlund; P Schraml; S Leighton; J Torhorst; M J Mihatsch; G Sauter; O P Kallioniemi
Journal:  Nat Med       Date:  1998-07       Impact factor: 53.440

10.  Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray.

Authors:  Y Hedberg; B Ljungberg; G Roos; G Landberg
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
View more
  4 in total

1.  Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential?

Authors:  M Horstmann; L M Geiger; U Vogel; H Schmid; J Hennenlotter; U Kuehs; A S Merseburger; S Kruck; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2011-09-18       Impact factor: 4.226

2.  Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.

Authors:  Axel S Merseburger; Mario W Kramer; Jörg Hennenlotter; Jürgen Serth; Stephan Kruck; Alfredo Gracia; Arnulf Stenzl; Markus A Kuczyk
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

3.  Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study.

Authors:  Isidro Machado; Francisco Giner; Empar Mayordomo; Carmen Carda; Samuel Navarro; Antonio Llombart-Bosch
Journal:  Diagn Pathol       Date:  2008-07-15       Impact factor: 2.644

4.  Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC).

Authors:  André P Nicklas; Mario W Kramer; Jürgen Serth; Jörg Hennenlotter; Marie C Hupe; Daniel U Reimer; Arnulf Stenzl; Axel S Merseburger; Markus A Kuczyk; Christoph-Alexander J von Klot
Journal:  Adv Ther       Date:  2018-09-19       Impact factor: 3.845
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.